Reverdia, the joint venture between Royal DSM and Roquette Frères, has in March been formally approved by the relevant regulatory authorities. The JV will produce biobased succinic acid through its proprietary production technology. The product will be marketed under the Biosuccinium brand.

read more: Reverdia JV launched